DKK1 and pancreatic neoplasm: DKK1-SE may be activated in the process of epigenetic reprogramming, and the dysregulation of histone modification caused by abnormal expression of TFs triggers the enhancement of modification of super-enhancers activity, which drives the occurrence and development of pancreatic cancer.